Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia

Parkinsonism and Related Disorders

Volumn 20, Issue 4, 2014, Pages 394-399

  Biundo, Roberta ^a   Weis, Luca ^a   Facchini, Silvia ^a   Formento Dojot, Patrizia ^a   Vallelunga, Annamaria ^a   Pilleri, Manuela ^a   Antonini, Angelo ^a  

^a Fondazione Ospedale San Camillo IRCCS   (Italy)

Author keywords

Cognitive tests; Cut off score; Dementia; Mild cognitive impairment; Neuropsychology; Parkinson disease

Indexed keywords

ADULT; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DEPTH PERCEPTION; DISEASE SEVERITY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCREENING TEST; SEMANTICS; SENSITIVITY AND SPECIFICITY; VERBAL MEMORY; AGED; COMPLICATION; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PSYCHOLOGY;

AGED; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84897960989     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.01.009     Document Type: Article

References (30)

1. Chaudhuri K.R., Schapira A.H. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009 May, 8(5):464-474.
2. Aarsland D., Andersen K., Larsen J.P., Lolk A., Nielsen H., Kragh-Sørensen P. Risk of dementia in Parkinson's disease: a community-based prospective study. Neurology 2001 Mar 27, 56(6):730-736.
3. Williams-Gray C.H., Mason S.L., Evans J.R., Foltynie T., Brayne C., Robbins T.W., et al. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. JNeurol Neurosurg Psychiatr 2013 Nov, 84(11):1258-1264.
4. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L. Wahlund LO mild cognitive impairment-beyond controversies towards a consensus: report of the International Working Group on Mild Cognitive Impairment. JIntern Med 2004, 256(3):240-246.
5. Litvan I., Aarsland D., Adler C.H., Goldman J.G., Kulisevsky J., Mollenhauer B., et al. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord 2011 Aug 15, 26(10):1814-1824.
6. Janvin C.C., Larsen J.P., Aarsland D., Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord 2006 Sep, 21(9):1343-1349.
7. Pedersen K.F., Larsen J.P., Tysnes O.B., Alves G. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurol 2013 May, 70(5):580-586.
8. Halliday G., Hely M., Reid W., Morris J. The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol 2008 Apr, 115(4):409-415.
9. Litvan I., Goldman J.G., Tröster A.I., Schmand B.A., Weintraub D., Petersen R.C., et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement Disorder Society Task Force guidelines. Mov Disord 2012 Mar, 27(3):349-356.
10. Marras C., Armstrong M.J., Meaney C.A., Fox S., Rothberg B., Reginold W., et al. Measuring mild cognitive impairment in patients with Parkinson's disease. Mov Disord 2013 May, 28(5):626-633.
11. Liepelt-Scarfone I., Graeber S., Feseker A., Baysal G., Godau J., Gaenslen A., et al. Influence of different cut-off values on the diagnosis of mild cognitive impairment in Parkinson's disease. Parkinsons Dis 23 May 2011, Published online. 10.4061/2011/540843.
12. Dalrymple-Alford J.C., Livingston L., MacAskill M.R., Graham C., Melzer T.R., Porter R.J., et al. Characterizing mild cognitive impairment in Parkinson's disease. Mov Disord 2011; Mar, 26(4):629-636.
13. Biundo R., Weis L., Pilleri M., Facchini S., Formento-Dojot P., Vallelunga A., et al. Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease. JNeural Transm 2013; Apr, 120(4):627-633.
14. Tomlinson C.L., Stowe R., Patel S., Rick C., Gray R., Clarke C.E. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010, 25(15):2649-2685.
15. Giovagnoli A.R., Del Pesce M., Mascheroni S., Simoncelli M., Laiacona M., Capitani E. Trail Making Test: normative values from 287 normal adult controls. Ital J Neurol Sci 1996, 17(4):305-309.
16. Spinnler H., Tognoni G. Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 1987, 6(Suppl 8):1-120.
17. Werheid K., Hoppe C., Thöne A., Müller U., Müngersdorf M., von Cramon D.Y. The Adaptive Digit Ordering Test: clinical application reliability and validity ofaverbal working memory test. Arch Clin Neuropsychol 2002 Aug, 17(6):547-565.
18. Novelli G., Papagno C., Capitani E., Laiacona M., Vallar G., Cappa S.F. Tre test clinici di ricerca e produzione lessicale: taratura su soggetti normali. Arch Psicol Neurol Psichiatr 1986, 47:477-506.
19. Caffarra P., Vezzadini G., Dieci F., Zonato F., Venneri A. Una versione abbreviata del test di Stroop. Dati normativi nella popolazione italiana. Nuova Riv Neurol 2002, 12:111-115.
20. Caffarra P., Vezzadini G., Dieci F., Zonato F., Venneri A. Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol Sci 2002, 22:443-447.
21. Novelli G., Papagno C., Capitani E., Laiacona M., Cappa S.F., Vallar G. Tre test clinici di memoria verbale a lungo termine. Taratura su soggetti normali. Arch Psicol Neurol Psichiatr 1986, 2(47):278-296.
22. Warrington E.K., James M. The visual Object and Space Perception battery (VOSP) 1991, Thames Valley Test Co, Bury St. Edmunds England.
23. Caffarra P., Gardini S., Zonato F., Concari L., Dieci F., Copelli S., et al. Italian norms for the Freedman version of the Clock Drawing Test. JClin Exp Neuropsychol 2011; Nov, 33(9):982-988.
24. Yamanishi T., Tachibana H., Oguru M., Matsui K., Toda K., Okuda B., et al. Anxiety and depression in patients with Parkinson's disease. Intern Med 2013, 52(5):539-545.
25. Dubois B., Burn D., Goetz C., Aarsland D., Brown R.G., Broe G.A., et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from themovement disorder society task force. Mov Disord 2007; Dec, 22(16):2314-2324.
26. Biundo R., Calabrese M., Weis L., Facchini S., Ricchieri G., Gallo P., et al. Anatomical correlates of cognitive functions in early Parkinson's disease patients. PLoS One 22 May 2013, Published online in. 10.1371/journal.pone.0064222.
27. Pagonabarraga J., Kulisevsky J., Llebaria G., García-Sánchez C., Pascual-Sedano B., Gironell A. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease. Mov Disord 2008 May 15, 23(7):998-1005.
28. Dalrymple-Alford J.C., MacAskill M.R., Nakas C.T., Livingston L., Graham C., Crucian G.P., et al. The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 2010 Nov 9, 75(19):1717-1725.
29. Aarsland D., Muniz G., Matthews F. Nonlinear decline of mini-mental state examination in Parkinson's disease. Mov Disord 2011 Feb 1, 26(2):334-337.
30. Aarsland D., Zaccai J., Brayne C. Asystematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 2005 Oct, 20(10):1255-1263.